SCHEMBL22845254

SCHEMBL22845254

Cn1c2c(n(C)c1=O)C=NC(C)(C)C=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22845497 0.84 ADORA2B (0.33) —
SCHEMBL22845481 0.63 ADORA2B (0.33) —
SCHEMBL22479947 0.57 — —
SCHEMBL141994 0.55 GSK3A (0.44) —
SCHEMBL24367516 0.55 — —
SCHEMBL24224672 0.55 — —
SCHEMBL22294701 0.52 — —
SCHEMBL12251815 0.51 GSK3A (0.36) —
SCHEMBL21788823 0.51 GSK3A (0.32) —
SCHEMBL20024617 0.50 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020263935-A1 HCK DEGRADERS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-12-30 — — WO disclosed
Send feedback